Nella popolazione pediatrica, la capacità di esercizio varia tra femmine e maschi e il divario si amplia durante l’adolescenza. Tuttavia, non sono stati riportati cambiamenti specifici basati sull’età e sul sesso negli adolescenti con cardiopatia congenita e palliazione di Fontan. Lo scopo del presente studio è identificare i cambiamenti specifici per età e sesso nella prestazione fisica al picco e nella soglia anaerobica ventilatoria (AT) per gli adolescenti con fisiologia Fontan. Revisione retrospettiva del set di dati di uso pubblico dello studio trasversale Pediatric Heart Network Fontan (Fontan 1). Sono stati effettuati confronti per i parametri di esercizio di picco e AT per femmine e maschi a intervalli di età di 2 anni.
Inoltre, i valori normativi sono stati generati dal sesso e dall’età a intervalli di 2 anni. Il check χ2 è stato utilizzato per il confronto per le variabili categoriali. I cambiamenti nei parametri di esercizio tra i gruppi di età in base al sesso sono stati confrontati dall’ANOVA con un’analisi post-hoc. Il check da sforzo è stato eseguito su 411 pazienti. L’AT è stata raggiunta in 317 soggetti (40% femmine), di cui 166 (43% femmine) hanno raggiunto il picco di esercizio. Il consumo massimo di ossigeno è diminuito del 32% durante l’adolescenza nelle femmine e non ha avuto il tipico aumento durante l’adolescenza per i maschi. Anche il consumo di ossigeno all’AT è diminuito con l’età in entrambi i sessi.
In conclusione, le prestazioni di esercizio basate sull’età e sul sesso per gli adolescenti con fisiologia Fontan sono prevedibilmente basse, ma ci sono ulteriori diminuzioni significative durante l’adolescenza per questa popolazione, specialmente nelle femmine. Abbiamo stabilito valori di esercizio normativi per diversi parametri per questa popolazione che identificheranno meglio i pazienti a rischio e consentiranno un intervento precoce. A una donna di 44 anni con una storia di carenza di fattore V Leiden ed emboli polmonari ricorrenti è stata diagnosticata la malattia da coronavirus 2019 (COVID-19) tre settimane prima si è presentata al suo ED locale con un forte dolore toracico. È stato riscontrato un ampio versamento pericardico emorragico mediante risonanza magnetica cardiaca con segni ecocardiografici di tamponamento. Ha subito la creazione di una finestra pericardica ed è stata trattata con colchicina con miglioramento dei sintomi.
Esercizi e fisiologia della pelle durante le spedizioni della stazione spaziale internazionale
Il primo esperimento pilota fisiologico della pelle (SkinA) su un singolo astronauta ha mostrato un deterioramento della pelle. In un esperimento di follow-up (SkinB) abbiamo dimostrato che i parametri fisiologici della pelle sono migliorati in media. Tuttavia, è noto che gli sport hanno effetti positivi sulla pelle, che gli astronauti preferiscono dispositivi sportivi speciali e praticano sport con intensità diversa. Lo scopo di questo studio è stato quello di analizzare le numerous attività sportive degli astronauti SkinB e di scoprire se hanno un’influenza sui parametri fisiologici della pelle
: La distanza cumulativa percorsa sul tapis roulant e sul cicloergometro nonché la ripetizione di Sono stati calcolati esercizi relativi alle braccia e analizzata la possibile correlazione tra attività sportive e parametri fisiologici della pelle. La distanza media percorsa per tutti e sei gli astronauti al giorno è di 1364 UA sul tapis roulant T2 e di 11.077 UA sul cicloergometro CEVIS. Inoltre, gli astronauti hanno eseguito una media di circa 73 ripetizioni di tutti gli esercizi relativi al braccio al giorno.
Qui, siamo stati in grado di mostrare molto bene quanto differissero gli astronauti sul treno ISS. Inoltre, negli astronauti si può osservare una tendenza alla diminuzione del quantity della pelle con l’aumento dell’attività sulla bicicletta e più ripetizioni sugli esercizi relativi alle braccia. L’aumento dell’attività sul cicloergometro e l’aumento degli esercizi relativi al braccio hanno un impatto medio negativo sul parametro quantity della pelle e quindi riflette il contenuto più fluido nella pelle. Non è stata trovata alcuna correlazione tra le attività sportive e l’idratazione della pelle / funzione di barriera cutanea.

Recettori nucleari che collegano la fisiologia e le cellule staminali germinali nella drosofila
La nutrizione e la fisiologia materna sono intimamente affiliate al successo riproduttivo in diversi organismi. Nonostante decenni di studi, i meccanismi molecolari che collegano la dieta materna alla produzione e alla qualità degli ovociti rimangono scarsamente definiti. I recettori nucleari (NR) collegano i segnali nutrizionali alle risposte cellulari e sono essenziali per lo sviluppo degli ovociti. Il moscerino della frutta, Drosophila melanogaster, è un eccellente modello geneticamente trattabile per studiare la relazione tra la segnalazione NR e la produzione di ovociti. In questa recensione, esploriamo come i NR nella Drosophila regolano le prime fasi dello sviluppo degli ovociti.
Urease (Recombinant) |
20-abx073924 |
Abbexa |
-
EUR 230.00
-
EUR 1344.00
-
EUR 328.00
|
|
|
Urease antibody |
20C-CR7022RP |
Fitzgerald |
1 ml |
EUR 133 |
Description: Rabbit polyclonal Urease antibody |
EX 527 (SEN0014196) |
A4181-10 |
ApexBio |
10 mg |
EUR 108 |
Description: EX 527 (SEN0014196) is a novel, potential, and specific small-molecule inhibitor of SIRT1 catalytic activity to examine the role of SIRT1 in p53 acetylation and cell survival after DNA damage |
EX 527 (SEN0014196) |
A4181-25 |
ApexBio |
25 mg |
EUR 177 |
Description: EX 527 (SEN0014196) is a novel, potential, and specific small-molecule inhibitor of SIRT1 catalytic activity to examine the role of SIRT1 in p53 acetylation and cell survival after DNA damage |
EX 527 (SEN0014196) |
A4181-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 108 |
Description: EX 527 (SEN0014196) is a novel, potential, and specific small-molecule inhibitor of SIRT1 catalytic activity to examine the role of SIRT1 in p53 acetylation and cell survival after DNA damage |
HP Urease Antigen |
E61H01201 |
EnoGene |
100ug |
EUR 343 |
EX-527 (SIRT1 inhibitor) |
SIH-353-25MG |
Stressmarq |
25 mg |
EUR 457 |
|
Description: The substance EX-527 is a sirt1 inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is light yellow solid which is soluble in 18 mg/ml DMSO or 10 mg/ml Ethanol. |
EX-527 (SIRT1 inhibitor) |
SIH-353-5MG |
Stressmarq |
5 mg |
EUR 163 |
|
Description: The substance EX-527 is a sirt1 inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is light yellow solid which is soluble in 18 mg/ml DMSO or 10 mg/ml Ethanol. |
SIRT1 Inhibitor, EX-527 |
1652-10 |
Biovision |
|
EUR 229 |
Urease subunit alpha Antibody |
20-abx110589 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Urease subunit beta Antibody |
20-abx110590 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
QuantiChrom Urease Assay Kit |
DURE-100 |
BioAssay Systems |
100 |
EUR 426 |
Description: Quantitative determination of urease activity by colorimetric (630nm) method. Procedure: 40 min. Kit size: 100 tests. Detection limit: 0.0014 U/L. Shelf life: 6 months. Shipping: ambient temp; storage: 4°C. |
Urease Activity Assay Kit |
55R-2261 |
Fitzgerald |
100 assays |
EUR 689 |
Description: Assay kit to measure Urease activity |
CardioDISC (Scaffold for cell culture) |
C-01-01-EX |
Sceti |
12 sheets |
Ask for price |
Description: The CardioDISC (Scaffold for cell culture) is available in Europe and for worldwide shipping via Gentaur. |
Urease subunit alpha Antibody (Biotin) |
20-abx106317 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Urease subunit beta Antibody (Biotin) |
20-abx106318 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Urease subunit alpha Antibody (FITC) |
20-abx107730 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Urease subunit beta Antibody (FITC) |
20-abx107731 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Urease subunit alpha Antibody (HRP) |
20-abx109148 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Urease subunit beta Antibody (HRP) |
20-abx109149 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Urease Activity Assay Kit (Colorimetric) |
K378-100 |
Biovision |
|
EUR 501 |
Plant Ex-Amp Extraction Buffer Set |
G934 |
ABM |
100 preps |
EUR 139 |
Concanavalin A Lectin from Canavalia ensiformis (Jack bean), purified and low endotoxin for cell culture |
CONA15-N |
Alpha Diagnostics |
5 mg |
EUR 408 |
wide horizontal unit 23.5x40 cm ex. port |
EHS3620-SYS |
Consort |
ea |
EUR 944 |
Deoxyribonucleic acid, sodium salt, ex salmon testes |
B1677-1 |
Biovision |
|
EUR 153 |
Deoxyribonucleic acid, sodium salt, ex salmon testes |
B1677-10 |
Biovision |
|
EUR 784 |
Deoxyribonucleic acid, sodium salt, ex salmon testes |
B1677-250 |
Biovision |
|
EUR 104 |
Deoxyribonucleic acid, sodium salt, ex salmon testes |
B1677-5 |
Biovision |
|
EUR 446 |
Helicobacter pylori Urease subunit alpha (ureA) |
1-CSB-YP320452HUV |
Cusabio |
-
EUR 679.00
-
EUR 335.00
-
EUR 2172.00
-
EUR 1051.00
-
EUR 1442.00
-
EUR 435.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Helicobacter pylori Urease subunit alpha(ureA) expressed in Yeast |
Helicobacter pylori Urease subunit beta (ureB) |
1-CSB-EP300910HUV |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Helicobacter pylori Urease subunit beta(ureB) expressed in E.coli |
Helicobacter pylori Urease subunit alpha (ureA) |
1-CSB-EP320452HUV |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Helicobacter pylori Urease subunit alpha(ureA) expressed in E.coli |
Plant Ex-Amp PCR Kit (with Kodaq MasterMix) |
G923 |
ABM |
25 preps 200 x 50ul reactions |
EUR 181 |
Tissue Ex-Amp PCR Kit (with Kodaq MasterMix) |
G927 |
ABM |
100 preps 120 x 50ul reactions |
EUR 130 |
Recombinant Campylobacter Pylori Urease subunit alpha Protein |
VAng-Lsx2720-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 1232 |
Description: Campylobacter Pylori Urease subunit alpha, recombinant protein from E. coli. |
Recombinant Campylobacter Pylori Urease subunit alpha Protein |
VAng-Lsx2720-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 846 |
Description: Campylobacter Pylori Urease subunit alpha, recombinant protein from E. coli. |
Recombinant Campylobacter Pylori Urease subunit alpha Protein |
VAng-Lsx2720-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 588 |
Description: Campylobacter Pylori Urease subunit alpha, recombinant protein from E. coli. |
Recombinant Helicobacter Pylori Urease, Small Subunit Protein |
VAng-Lsx3196-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 3829 |
Description: Helicobacter Pylori Urease, Small Subunit, recombinant protein. |
Recombinant Helicobacter Pylori Urease, Small Subunit Protein |
VAng-Lsx3196-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 2601 |
Description: Helicobacter Pylori Urease, Small Subunit, recombinant protein. |
Recombinant Helicobacter Pylori Urease, Small Subunit Protein |
VAng-Lsx3196-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 1770 |
Description: Helicobacter Pylori Urease, Small Subunit, recombinant protein. |
Recombinant Helicobacter Pylori Urease, Large Subunit Protein |
VAng-Lsx3201-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 3829 |
Description: Helicobacter Pylori Urease, Large Subunit, recombinant protein from E. coli. |
Recombinant Helicobacter Pylori Urease, Large Subunit Protein |
VAng-Lsx3201-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 2601 |
Description: Helicobacter Pylori Urease, Large Subunit, recombinant protein from E. coli. |
Recombinant Helicobacter Pylori Urease, Large Subunit Protein |
VAng-Lsx3201-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 1770 |
Description: Helicobacter Pylori Urease, Large Subunit, recombinant protein from E. coli. |
Recombinant other Urease Protein, Untagged, E.coli-1mg |
QP10907-1mg |
EnQuireBio |
1mg |
EUR 155 |
Recombinant other Urease Protein, Untagged, E.coli-50mg |
QP10907-50mg |
EnQuireBio |
50mg |
EUR 1043 |
Recombinant other Urease Protein, Untagged, E.coli-5mg |
QP10907-5mg |
EnQuireBio |
5mg |
EUR 201 |
Holder for Plasmid Midi, Maxi and Maxi plus, Ion Exchange column |
FAPDE-holder-for-ion-exchange |
Favorgen |
1 prep |
EUR 158 |
Human urease related protein C(UreC)ELISA Kit |
GA-E0803HM-48T |
GenAsia Biotech |
48T |
EUR 289 |
Human urease related protein C(UreC)ELISA Kit |
GA-E0803HM-96T |
GenAsia Biotech |
96T |
EUR 466 |
Human urease related protein C,UreC ELISA Kit |
201-12-0787 |
SunredBio |
96 tests |
EUR 440 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Pig Urease Related Protein C (UreC) ELISA Kit |
abx360642-96tests |
Abbexa |
96 tests |
EUR 825 |
|
Rabbit Urease Related Protein C (UreC) ELISA Kit |
abx363638-96tests |
Abbexa |
96 tests |
EUR 825 |
|
Human Urease Related Protein C (UreC) ELISA Kit |
abx354523-96tests |
Abbexa |
96 tests |
EUR 786 |
|
Chicken Urease Related Protein C (UreC) ELISA Kit |
abx355723-96tests |
Abbexa |
96 tests |
EUR 825 |
|
Monkey Urease Related Protein C (UreC) ELISA Kit |
abx358934-96tests |
Abbexa |
96 tests |
EUR 825 |
|
H. pylori anitgen pure (CagA+VacA+Urease antigens) |
HPY15-N-100 |
Alpha Diagnostics |
100 ug |
EUR 225 |
Human urease related protein C,UreC ELISA Kit |
CN-04181H1 |
ChemNorm |
96T |
EUR 467 |
Human urease related protein C,UreC ELISA Kit |
CN-04181H2 |
ChemNorm |
48T |
EUR 316 |
HAND1 ELISA Kit| chicken Heart- and neural crest derivatives-ex |
EF012329 |
Lifescience Market |
96 Tests |
EUR 689 |
HAND2 ELISA Kit| chicken Heart- and neural crest derivatives-ex |
EF012330 |
Lifescience Market |
96 Tests |
EUR 689 |
Guinea pig Urease Related Protein C (UreC) ELISA Kit |
abx357514-96tests |
Abbexa |
96 tests |
EUR 825 |
|
Adaptor for flexible plates, accessory for AgileSealer? |
APS-200-FP |
ACTGene |
|
EUR 351 |
Sample comb for batching for AE-6110 |
2398313 |
Atto |
unit |
EUR 100 |
Description: (90mm・r efer ence at t ached・1.5mm t i ck ness) |
gelcaster for sequencer |
ESEQ1000-CAST |
Consort |
ea |
EUR 437 |
Stand for D1000 |
BCM1237 |
Bio Basic |
1 pcs, 1 UNIT |
EUR 556.7 |
|
Antibody for CD9 |
SPC-1272D |
Stressmarq |
0.1ml |
EUR 314 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is unconjugated. |
Antibody for CD9 |
SPC-1272D-A390 |
Stressmarq |
0.1ml |
EUR 361 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 390. |
Antibody for CD9 |
SPC-1272D-A488 |
Stressmarq |
0.1ml |
EUR 360 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 488. |
Antibody for CD9 |
SPC-1272D-A565 |
Stressmarq |
0.1ml |
EUR 360 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 565. |
Antibody for CD9 |
SPC-1272D-A594 |
Stressmarq |
0.1ml |
EUR 360 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 594. |
Antibody for CD9 |
SPC-1272D-A633 |
Stressmarq |
0.1ml |
EUR 360 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 633. |
Antibody for CD9 |
SPC-1272D-A655 |
Stressmarq |
0.1ml |
EUR 360 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 655. |
Antibody for CD9 |
SPC-1272D-A680 |
Stressmarq |
0.1ml |
EUR 360 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 680. |
Antibody for CD9 |
SPC-1272D-A700 |
Stressmarq |
0.1ml |
EUR 360 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 700. |
Antibody for CD9 |
SPC-1272D-ALP |
Stressmarq |
0.1ml |
EUR 355 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Alkaline Phosphatase. |
Antibody for CD9 |
SPC-1272D-APC |
Stressmarq |
0.1ml |
EUR 359 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to APC . |
Antibody for CD9 |
SPC-1272D-APCCY7 |
Stressmarq |
0.1ml |
EUR 432 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to APC/Cy7. |
Antibody for CD9 |
SPC-1272D-BI |
Stressmarq |
0.1ml |
EUR 357 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Biotin. |
Antibody for CD9 |
SPC-1272D-DY350 |
Stressmarq |
0.1ml |
EUR 436 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Dylight 350. |
Antibody for CD9 |
SPC-1272D-DY405 |
Stressmarq |
0.1ml |
EUR 412 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Dylight 405. |
Antibody for CD9 |
SPC-1272D-DY488 |
Stressmarq |
0.1ml |
EUR 393 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Dylight 488. |
Antibody for CD9 |
SPC-1272D-DY594 |
Stressmarq |
0.1ml |
EUR 397 |
|
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Dylight 594. |
Riconosciuto da tempo come mediatore essenziale delle transizioni evolutive, ci concentriamo sui ruoli intrinseci del recettore Ecdysone e del suo ligando, ecdysone, nell’oogenesi. Esaminiamo anche studi recenti che suggeriscono ruoli più ampi per NR come regolatori della fisiologia materna e il loro impatto specifico sulla produzione di ovociti. Proponiamo che gli NR costituiscano la base molecolare di un’ampia rete di sorveglianza fisiologica che collega la dieta materna alla produzione di ovociti. Data la conservazione funzionale tra Drosophila e gli esseri umani, la continua indagine sperimentale sui meccanismi molecolari mediante i quali gli NR promuovono l’oogenesi probabilmente aiuterà la nostra comprensione della fertilità umana.